| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80005-112-12 | 80005-112 | HUMAN PRESCRIPTION DRUG | ETRAVIRINE | ETRAVIRINE | TABLET | ORAL | 20220607 | N/A | ANDA | ANDA215402 | Carnegie Pharmaceuticals LLC | ETRAVIRINE | 100 mg/1 | 120 TABLET in 1 BOTTLE (80005-112-12) |
| 80005-113-09 | 80005-113 | HUMAN PRESCRIPTION DRUG | ETRAVIRINE | ETRAVIRINE | TABLET | ORAL | 20220607 | N/A | ANDA | ANDA215402 | Carnegie Pharmaceuticals LLC | ETRAVIRINE | 200 mg/1 | 60 TABLET in 1 BOTTLE (80005-113-09) |
| 69315-285-20 | 69315-285 | HUMAN PRESCRIPTION DRUG | ETRAVIRINE | ETRAVIRINE | TABLET | ORAL | 20220605 | N/A | ANDA | ANDA215402 | Leading Pharma, LLC | ETRAVIRINE | 100 mg/1 | 120 TABLET in 1 BOTTLE (69315-285-20) |
| 69315-286-06 | 69315-286 | HUMAN PRESCRIPTION DRUG | ETRAVIRINE | ETRAVIRINE | TABLET | ORAL | 20220605 | N/A | ANDA | ANDA215402 | Leading Pharma, LLC | ETRAVIRINE | 200 mg/1 | 60 TABLET in 1 BOTTLE (69315-286-06) |